Acute Porphyria Drug Database

M01AE03 - Ketoprofen
Propably not porphyrinogenic
PNP

Rationale
Probably CYP (2C9?) substrate. No data pointing to CYP-induction Two references consider it (probably) safe.
Chemical description
Caps./supp. 50-200 mg/d. Analgetic and antiflogistic propionic acid derivative. Metabolized (2C9?) in the liver )by conjugation with glucuronic acid. South African list: use with care. French list: authorized. C.Andersson; patient reports: tolerated (n=1).

Similar drugs
Explore alternative drugs in similar therapeutic classes M01A / M01AE or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙